Hair Regrowth in Alopecia Areata and Re-pigmentation in Vitiligo in Response to Treatment: Commonalities and Differences

Overview

Journal J Eur Acad Dermatol Venereol

Specialty Infectious Diseases

Date 2024 Sep 11

PMID 39258892

Authors

Hiroki L Yamaguchi

Yuji Yamaguchi

Elena Peeva

Affiliations

Soon will be listed here.

Abstract

Both alopecia areata (AA) and vitiligo share common pathogenesis involving, interferon-γ (IFN-γ) and interleukin-15 (IL-15) signalling pathways that activate cytotoxic CD8+ T lymphocytes. These shared mechanisms may explain why both diseases respond to currently available treatments (e.g. topical/systemic corticosteroid) and emerging treatment modalities. As compared with the speed of re-pigmentation in vitiligo lesions, the regeneration of pigmented terminal hair follicles in AA lesions appears fast in response to treatments targeting the inhibition of the Janus kinases (JAKs) and other kinases. We summarize the commonalities and differences between AA and vitiligo focusing on the treatment modalities, followed by recent findings associated with hair follicle stem cells (HFSC) in hair bulge (HBg) and melanocyte stem cells (McSC) in HBg and hair germ (HGm). We then discuss how HFSC and HGm-McSC are involved in the initiation of anagen phase, followed by pigmented terminal hair regrowth in the recovering AA lesions in association with immunology. We also discuss how HBg-McSC contribute to the migration of fully dendritic mature melanocytes into interfollicular epidermis and the equal distribution of melanin in recovering vitiligo lesions. Finally, we present four hypotheses to elucidate the delayed distribution of melanin by mature melanocytes in depigmented vitiligo lesions from the aspects of stem cell biology, as compared with quick hair recovery in AA: (1) McSC are less abundant than HFSC. (2) McSC require a long travel, whereas HFSC reside close to hair regeneration trigger point. (3) Keratinocyte scaffold to accept melanin is not well preserved, whereas scaffold for hair regrowth is well preserved. (4) Inhibitors targeting JAKs and other kinases have less direct effects on melanocyte proliferation and differentiation in vitiligo than hair regrowth in AA. Our review provides an overview of treatment modalities and bridges the gap between scientific advancement and clinical practice in AA and vitiligo management.

Citing Articles

Hair regrowth in alopecia areata and re-pigmentation in vitiligo in response to treatment: Commonalities and differences.

Yamaguchi H, Yamaguchi Y, Peeva E J Eur Acad Dermatol Venereol. 2024; 39(3):498-511.

PMID: 39258892 PMC: 11851261. DOI: 10.1111/jdv.20311.

References

Allouche J, Rachmin I, Adhikari K, Pardo L, Lee J, McConnell A . NNT mediates redox-dependent pigmentation via a UVB- and MITF-independent mechanism. Cell. 2021; 184(16):4268-4283.e20. PMC: 8349839. DOI: 10.1016/j.cell.2021.06.022. View

Yuan X, Jin Z . Paracrine regulation of melanogenesis. Br J Dermatol. 2017; 178(3):632-639. DOI: 10.1111/bjd.15651. View

Petukhova L, Duvic M, Hordinsky M, Norris D, Price V, Shimomura Y . Genome-wide association study in alopecia areata implicates both innate and adaptive immunity. Nature. 2010; 466(7302):113-7. PMC: 2921172. DOI: 10.1038/nature09114. View

Tadokoro T, Yamaguchi Y, Batzer J, Coelho S, Zmudzka B, Miller S . Mechanisms of skin tanning in different racial/ethnic groups in response to ultraviolet radiation. J Invest Dermatol. 2005; 124(6):1326-32. DOI: 10.1111/j.0022-202X.2005.23760.x. View

Okamoto N, Aoto T, Uhara H, Yamazaki S, Akutsu H, Umezawa A . A melanocyte--melanoma precursor niche in sweat glands of volar skin. Pigment Cell Melanoma Res. 2014; 27(6):1039-50. DOI: 10.1111/pcmr.12297. View

Esmat S, El Hadidi H, Hegazy R, Gawdat H, Tawdy A, Fawzy M . Increased tenascin C and DKK1 in vitiligo: possible role of fibroblasts in acral and non-acral disease. Arch Dermatol Res. 2018; 310(5):425-430. DOI: 10.1007/s00403-018-1830-z. View

Hsu Y, Li L, Fuchs E . Emerging interactions between skin stem cells and their niches. Nat Med. 2014; 20(8):847-56. PMC: 4358898. DOI: 10.1038/nm.3643. View

Fesse P, Nyman J, Hermansson I, Book M, Ahlgren J, Turesson I . Human cutaneous interfollicular melanocytes differentiate temporarily under genotoxic stress. iScience. 2022; 25(10):105238. PMC: 9579029. DOI: 10.1016/j.isci.2022.105238. View

Schaeffer E, Debnath J, Yap G, McVicar D, Liao X, Littman D . Requirement for Tec kinases Rlk and Itk in T cell receptor signaling and immunity. Science. 1999; 284(5414):638-41. DOI: 10.1126/science.284.5414.638. View

10.

Harel S, Higgins C, Cerise J, Dai Z, Chen J, Clynes R . Pharmacologic inhibition of JAK-STAT signaling promotes hair growth. Sci Adv. 2015; 1(9):e1500973. PMC: 4646834. DOI: 10.1126/sciadv.1500973. View

11.

Chang C, Pasolli H, Giannopoulou E, Guasch G, Gronostajski R, Elemento O . NFIB is a governor of epithelial-melanocyte stem cell behaviour in a shared niche. Nature. 2013; 495(7439):98-102. PMC: 3635831. DOI: 10.1038/nature11847. View

12.

Yamaguchi Y, Hearing V . Physiological factors that regulate skin pigmentation. Biofactors. 2009; 35(2):193-9. PMC: 2793097. DOI: 10.1002/biof.29. View

13.

Ryan G, Harris J, Richmond J . Resident Memory T Cells in Autoimmune Skin Diseases. Front Immunol. 2021; 12:652191. PMC: 8128248. DOI: 10.3389/fimmu.2021.652191. View

14.

Xing L, Dai Z, Jabbari A, Cerise J, Higgins C, Gong W . Alopecia areata is driven by cytotoxic T lymphocytes and is reversed by JAK inhibition. Nat Med. 2014; 20(9):1043-9. PMC: 4362521. DOI: 10.1038/nm.3645. View

15.

Lu Z, Xie Y, Huang H, Jiang K, Zhou B, Wang F . Hair follicle stem cells regulate retinoid metabolism to maintain the self-renewal niche for melanocyte stem cells. Elife. 2020; 9. PMC: 6970533. DOI: 10.7554/eLife.52712. View

16.

Guttman-Yassky E, Pavel A, Diaz A, Zhang N, Del Duca E, Estrada Y . Ritlecitinib and brepocitinib demonstrate significant improvement in scalp alopecia areata biomarkers. J Allergy Clin Immunol. 2021; 149(4):1318-1328. DOI: 10.1016/j.jaci.2021.10.036. View

17.

Migayron L, Boniface K, Seneschal J . Vitiligo, From Physiopathology to Emerging Treatments: A Review. Dermatol Ther (Heidelb). 2020; 10(6):1185-1198. PMC: 7649199. DOI: 10.1007/s13555-020-00447-y. View

18.

Cheuk S, Schlums H, Gallais Serezal I, Martini E, Chiang S, Marquardt N . CD49a Expression Defines Tissue-Resident CD8 T Cells Poised for Cytotoxic Function in Human Skin. Immunity. 2017; 46(2):287-300. PMC: 5337619. DOI: 10.1016/j.immuni.2017.01.009. View

19.

Seneschal J, Speeckaert R, Taieb A, Wolkerstorfer A, Passeron T, Pandya A . Worldwide expert recommendations for the diagnosis and management of vitiligo: Position statement from the international Vitiligo Task Force-Part 2: Specific treatment recommendations. J Eur Acad Dermatol Venereol. 2023; 37(11):2185-2195. DOI: 10.1111/jdv.19450. View

20.

Yamaguchi H, Yamaguchi Y, Peeva E . Hair regrowth in alopecia areata and re-pigmentation in vitiligo in response to treatment: Commonalities and differences. J Eur Acad Dermatol Venereol. 2024; 39(3):498-511. PMC: 11851261. DOI: 10.1111/jdv.20311. View